Search research articles
Contact Us
Filters
Showing results (11-20 of 155) with videos related to
Page
of 16
Sort By:
Cancer Cell
|
April 20, 2005
Building better therapy for children with acute lymphoblastic leukemia
William L Carroll, Elizabeth A Raetz
The Journal of Pediatrics
|
September 17, 2011
Clinical and laboratory biology of childhood acute lymphoblastic leukemia
William L Carroll, Elizabeth A Raetz
Hematology. American Society of Hematology. Education Program
|
December 4, 2016
T-cell acute lymphoblastic leukemia
Elizabeth A Raetz, David T Teachey
Blood Advances
|
July 1, 2026
Reaching consensus in relapsed/refractory ALL in AYAs
Elizabeth A Raetz, William L Carroll
Best Practice & Research. Clinical Haematology
|
October 21, 2017
How is the Ph-like signature being incorporated into ALL therapy?
Luke Maese, Sarah K Tasian, Elizabeth A Raetz
Pediatric Blood & Cancer
|
March 3, 2025
The ASPHO 2025 Distinguished Career Award Goes to Dr. William L. Carroll
Elizabeth A Raetz, Mignon L Loh, Stephen P Hunger
Paediatric Drugs
|
May 26, 2007
Potential of gene expression profiling in the management of childhood acute lymphoblastic leukemia
Deepa Bhojwani, Naomi Moskowitz, Elizabeth A Raetz, et al.
Personalized Medicine
|
May 24, 2018
Individualized therapy for childhood acute lymphoblastic leukemia
Elizabeth A Raetz, Deepa Bhojwani, Dong-Joon Min, et al.
Pediatric Blood & Cancer
|
March 4, 2011
Improving outcomes for high-risk ALL: translating new discoveries into clinical care
Stephen P Hunger, Elizabeth A Raetz, Mignon L Loh, et al.
Pediatric Blood & Cancer
|
December 21, 2005
Childhood acute lymphoblastic leukemia in the age of genomics
William L Carroll, Deepa Bhojwani, Dong-Joon Min, et al.
Page
of 16
Search research articles
Search
Showing results (11-20 of 155) with videos related to
Sort By:
Page
of 16
Cancer Cell
|
April 20, 2005
Building better therapy for children with acute lymphoblastic leukemia
William L Carroll, Elizabeth A Raetz
The Journal of Pediatrics
|
September 17, 2011
Clinical and laboratory biology of childhood acute lymphoblastic leukemia
William L Carroll, Elizabeth A Raetz
Hematology. American Society of Hematology. Education Program
|
December 4, 2016
T-cell acute lymphoblastic leukemia
Elizabeth A Raetz, David T Teachey
Blood Advances
|
July 1, 2026
Reaching consensus in relapsed/refractory ALL in AYAs
Elizabeth A Raetz, William L Carroll
Best Practice & Research. Clinical Haematology
|
October 21, 2017
How is the Ph-like signature being incorporated into ALL therapy?
Luke Maese, Sarah K Tasian, Elizabeth A Raetz
Pediatric Blood & Cancer
|
March 3, 2025
The ASPHO 2025 Distinguished Career Award Goes to Dr. William L. Carroll
Elizabeth A Raetz, Mignon L Loh, Stephen P Hunger
Paediatric Drugs
|
May 26, 2007
Potential of gene expression profiling in the management of childhood acute lymphoblastic leukemia
Deepa Bhojwani, Naomi Moskowitz, Elizabeth A Raetz, et al.
Personalized Medicine
|
May 24, 2018
Individualized therapy for childhood acute lymphoblastic leukemia
Elizabeth A Raetz, Deepa Bhojwani, Dong-Joon Min, et al.
Pediatric Blood & Cancer
|
March 4, 2011
Improving outcomes for high-risk ALL: translating new discoveries into clinical care
Stephen P Hunger, Elizabeth A Raetz, Mignon L Loh, et al.
Pediatric Blood & Cancer
|
December 21, 2005
Childhood acute lymphoblastic leukemia in the age of genomics
William L Carroll, Deepa Bhojwani, Dong-Joon Min, et al.
Page
of 16